2015 Archived Content
Record Attendance in 2015
For the fourth year in a row, a record number of delegates participated in PEGS Europe! 700 attendees from more than 30 countries participated this year with even more expected in 2016. 46% of attendees were Scientists and another 27% were Executives or Directors. 21% of attendees were from Big Pharma, 49% from biotech, and 22% from academia.
Download 2015 Brochure
“Best biologics engineering and technology conference: a must-attend conference for novel biologics.”
- Rakesh D., Ph.D., VP, R&D, MedImmune
“PEGS Europe and PEGS keep going from strength to strength. One week at a PEGS event can stimulate ideas for a whole year.”
- Kevin R., Ph.D., Scientist, Wellcome Trust Sanger Institute
“Once more, PEGS Europe was an outstanding event with great science and a perfect setting for networking. Very nice combination of topics and speakers.”
- Philipp M., Ph.D., Project Leader, Biomedicine, University Hospital of Basel
“PEGS Europe is a gem for protein engineers with depth and breadth in a stimulating and engaging environment! I am glad that I came all the way from California to be a part of it!”
- Seung C., Ph.D., Associate Director, Cell Biology, Xencor, Inc.
Read More Testimonials
Streamlining Protein Expression & Production
Lorenz Mayr, Ph.D., AstraZeneca
Current and Future Trends in Antibody Therapeutics
Paul W.H.I. Parren, Ph.D., Genmab B.V.
Protein Engineering for New Modes of Actions & New Targets
Andreas Plückthun, Ph.D., University of Zurich
Targeting Ion Channels
Tristan J. Vaughan, Ph.D., MedImmune Ltd.
Mechanically Refolding Proteins beyond Unboiling an Egg
Gregory A. Weiss, Ph.D., University of California, Irvine